COYA-204

N/A

Report date: 2025/08/19 14:10:05

Base Information

Drug NameCOYA-204
Drug Alias Nameallogeneic regulatory T-cell derived exosome therapy (Coya Therapeutics)COYA-204
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapyBiologics > Exosomes
Mechanisms of ActionImmunomodulatorsRegulatory T-lymphocytes modulators
TargetsNot applicable
Therapy Area/IndicationsScleroderma, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCoya Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCoya Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsScleroderma, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A